Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
Biotech stocks
Tag: biotech stocks
Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...
ME Contributor
-
November 8, 2017
0
Biotech Movers: Versartis, Inc. (NASDAQ:VSAR) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
ME Contributor
-
September 22, 2017
0
Biotech Movers: Novartis AG (ADR) (NYSE:NVS), Otonomy, Inc. (NASDAQ:OTIC)
ME Contributor
-
August 31, 2017
0
Biotech Movers: Eleven Biotherapeutics Inc (NASDAQ:EBIO) and Horizon Pharma PLC (NASDAQ:HZNP)
ME Contributor
-
August 21, 2017
0
Here’s Why Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Have A Rough December
ME Contributor
-
November 18, 2016
0
AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo...
ME Contributor
-
November 3, 2016
1
Intersect ENT Inc (NASDAQ:XENT) Is An Opportunity To Get In On...
ME Contributor
-
October 18, 2016
0
Coherus Biosciences Inc (NASDAQ:CHRS) Has Set Its Sights On Amgen, Inc....
ME Contributor
-
August 16, 2016
0
Oramed Gets Buy Rating From FBR & Co. Target: $20
ME Contributor
-
July 29, 2016
0
Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update
ME Contributor
-
May 4, 2016
0
1
2
Page 1 of 2
/* */
// AST – IMS - [MarketExclusive_ROS]